Compile Data Set for Download or QSAR
maximum 50k data
Found 96 Enz. Inhib. hit(s) with all data for entry = 1704
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336124(US9744148, 1)
Affinity DataIC50:  39nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336128(US9744148, 2)
Affinity DataIC50:  70nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336129(US9744148, 3)
Affinity DataIC50:  80nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336130(US9744148, 4)
Affinity DataIC50:  80nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336132(US9744148, 5)
Affinity DataIC50:  90nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336133(US9744148, 6)
Affinity DataIC50:  120nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336134(US9744148, 7)
Affinity DataIC50:  130nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336135(US9744148, 8)
Affinity DataIC50:  140nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336138(US9744148, 11)
Affinity DataIC50:  150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336137(US9744148, 10 | US9744148, 31)
Affinity DataIC50:  150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336136(US9744148, 9)
Affinity DataIC50:  150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336142(US9744148, 12 | US9744148, 23)
Affinity DataIC50:  150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336143(US9744148, 13)
Affinity DataIC50:  170nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336145(US9744148, 14)
Affinity DataIC50:  180nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336146(US9744148, 15)
Affinity DataIC50:  180nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336147(US9744148, 16)
Affinity DataIC50:  190nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336148(US9744148, 17)
Affinity DataIC50:  190nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336149(US9744148, 18)
Affinity DataIC50:  220nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336150(US9744148, 19)
Affinity DataIC50:  230nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336151(US9744148, 20)
Affinity DataIC50:  230nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336152(US9744148, 21)
Affinity DataIC50:  260nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336153(US9744148, 22)
Affinity DataIC50:  260nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336142(US9744148, 12 | US9744148, 23)
Affinity DataIC50:  270nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336155(US9744148, 24)
Affinity DataIC50:  280nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336156(US9744148, 25)
Affinity DataIC50:  310nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336157(US9744148, 26)
Affinity DataIC50:  320nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336158(US9744148, 27)
Affinity DataIC50:  330nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336159(US9744148, 28)
Affinity DataIC50:  340nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336160(US9744148, 29)
Affinity DataIC50:  350nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336161(US9744148, 30)
Affinity DataIC50:  360nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336137(US9744148, 10 | US9744148, 31)
Affinity DataIC50:  370nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336163(US9744148, 32)
Affinity DataIC50:  380nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336164(US9744148, 33)
Affinity DataIC50:  390nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336165(US9744148, 34)
Affinity DataIC50:  390nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336166(US9744148, 35)
Affinity DataIC50:  410nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336167(US9744148, 36)
Affinity DataIC50:  430nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336168(US9744148, 37)
Affinity DataIC50:  460nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336169(US9744148, 38)
Affinity DataIC50:  470nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336170(US9744148, 39)
Affinity DataIC50:  480nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336171(US9744148, 40)
Affinity DataIC50:  550nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336172(US9744148, 41)
Affinity DataIC50:  580nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336173(US9744148, 42)
Affinity DataIC50:  590nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336174(US9744148, 43)
Affinity DataIC50:  630nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336175(US9744148, 44)
Affinity DataIC50:  640nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336176(US9744148, 45 | US9744148, 85)
Affinity DataIC50:  660nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336177(US9744148, 46)
Affinity DataIC50:  690nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336178(US9744148, 47)
Affinity DataIC50:  740nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336179(US9744148, 48)
Affinity DataIC50:  760nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336180(US9744148, 49)
Affinity DataIC50:  780nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336181(US9744148, 50)
Affinity DataIC50:  790nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 96 total ) | Next | Last >>
Jump to: